活性化部分トロンボプラスチン時間検査(APTT検査)の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1757)
◆英語タイトル:Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1757
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、活性化部分トロンボプラスチン時間検査(APTT検査)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(光学技術、機械技術、電気化学技術)、用途別市場規模(ヘパリン療法モニタリング、凝固因子欠損症スクリーニング、凝固阻害剤、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・活性化部分トロンボプラスチン時間検査(APTT検査)の市場動向
・企業の競争状況、市場シェア
・活性化部分トロンボプラスチン時間検査(APTT検査)の種類別市場規模(光学技術、機械技術、電気化学技術)
・活性化部分トロンボプラスチン時間検査(APTT検査)の用途別市場規模(ヘパリン療法モニタリング、凝固因子欠損症スクリーニング、凝固阻害剤、その他)
・活性化部分トロンボプラスチン時間検査(APTT検査)の北米市場規模2016-2027(アメリカ、カナダ)
・活性化部分トロンボプラスチン時間検査(APTT検査)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・活性化部分トロンボプラスチン時間検査(APTT検査)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・活性化部分トロンボプラスチン時間検査(APTT検査)の中南米市場規模2016-2027(メキシコ、ブラジル)
・活性化部分トロンボプラスチン時間検査(APTT検査)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Medtronic、Abbott、Roche Diagnostics、Siemens Healthineers、Haemonetics、Sysmex、Danaher、Bio-Rad Laboratories、bioMerieux、Eiken Chemical、Life Technologies、Becton, Dickinson and Company)
・結論
【レポートの概要】

Market Analysis and Insights: Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market
The global Activated Partial Thromboplastin Time Testing (APTT Testing) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Activated Partial Thromboplastin Time Testing (APTT Testing) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Activated Partial Thromboplastin Time Testing (APTT Testing) market.

Global Activated Partial Thromboplastin Time Testing (APTT Testing) Scope and Market Size
Activated Partial Thromboplastin Time Testing (APTT Testing) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Optical Technology
Mechanical Technology
Electrochemical Technology

Segment by Application
Heparin Therapy Monitoring
Coagulation Factor Deficiencies Screening
Coagulation Inhibitors
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medtronic
Abbott
Roche Diagnostics
Siemens Healthineers
Haemonetics
Sysmex
Danaher
Bio-Rad Laboratories
bioMerieux
Eiken Chemical
Life Technologies
Becton, Dickinson and Company

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Optical Technology
1.2.3 Mechanical Technology
1.2.4 Electrochemical Technology
1.3 Market by Application
1.3.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heparin Therapy Monitoring
1.3.3 Coagulation Factor Deficiencies Screening
1.3.4 Coagulation Inhibitors
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Perspective (2016-2027)
2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Growth Trends by Regions
2.2.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Share by Regions (2016-2021)
2.2.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Regions (2022-2027)
2.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Industry Dynamic
2.3.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Trends
2.3.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Drivers
2.3.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Challenges
2.3.4 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Revenue
3.1.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Revenue (2016-2021)
3.1.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Players (2016-2021)
3.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue
3.4 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio
3.4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue in 2020
3.5 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players Head office and Area Served
3.6 Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Product Solution and Service
3.7 Date of Enter into Activated Partial Thromboplastin Time Testing (APTT Testing) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Activated Partial Thromboplastin Time Testing (APTT Testing) Breakdown Data by Type
4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Size by Type (2016-2021)
4.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Type (2022-2027)

5 Activated Partial Thromboplastin Time Testing (APTT Testing) Breakdown Data by Application
5.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Size by Application (2016-2021)
5.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
6.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
6.2.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
6.2.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
6.2.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
6.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
6.3.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
6.3.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
6.3.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
6.4 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
6.4.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
6.4.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
7.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
7.2.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
7.2.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
7.2.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
7.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
7.3.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
7.3.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
7.3.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
7.4 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
7.4.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
7.4.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
8.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
8.2.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
8.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
8.3.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
8.4 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region
8.4.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
9.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
9.2.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
9.2.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
9.2.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
9.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
9.3.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
9.3.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
9.3.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
9.4 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
9.4.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
9.4.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
10.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
10.2.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
10.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
10.3.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
10.4 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
10.4.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.1.4 Medtronic Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.2.4 Abbott Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.3.4 Roche Diagnostics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.3.5 Roche Diagnostics Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.4.4 Siemens Healthineers Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.4.5 Siemens Healthineers Recent Development
11.5 Haemonetics
11.5.1 Haemonetics Company Details
11.5.2 Haemonetics Business Overview
11.5.3 Haemonetics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.5.4 Haemonetics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.5.5 Haemonetics Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.6.4 Sysmex Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.6.5 Sysmex Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.7.4 Danaher Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.8.4 Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 bioMerieux
11.9.1 bioMerieux Company Details
11.9.2 bioMerieux Business Overview
11.9.3 bioMerieux Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.9.4 bioMerieux Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.9.5 bioMerieux Recent Development
11.10 Eiken Chemical
11.10.1 Eiken Chemical Company Details
11.10.2 Eiken Chemical Business Overview
11.10.3 Eiken Chemical Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.10.4 Eiken Chemical Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.10.5 Eiken Chemical Recent Development
11.11 Life Technologies
11.11.1 Life Technologies Company Details
11.11.2 Life Technologies Business Overview
11.11.3 Life Technologies Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.11.4 Life Technologies Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.11.5 Life Technologies Recent Development
11.12 Becton, Dickinson and Company
11.12.1 Becton, Dickinson and Company Company Details
11.12.2 Becton, Dickinson and Company Business Overview
11.12.3 Becton, Dickinson and Company Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.12.4 Becton, Dickinson and Company Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.12.5 Becton, Dickinson and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 活性化部分トロンボプラスチン時間検査(APTT検査)の世界市場規模・現状・予測2021年-2027年(Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。